Jialiang Medical Showcases Epilcure Closed-Loop Neuromodulation System at WAIC 2025, Garnering Widespread Attention

On July 26, 2025, the highly anticipated World Artificial Intelligence Conference (WAIC 2025) grandly opened at the Shanghai Expo Exhibition Hall. As a pioneer in China in the application of brain-computer interface technology in the field of neurological disease treatment, Genlight NeurotechEpilcureImplantable Closed-Loop Self-Responsive Neurostimulation System, making a grand appearance at booth E920 in Hall H2, quickly becoming one of the highlights of the exhibition.

On the first day of the exhibition, the GenLight booth attracted a high level of attention. Professional visitors, industry partners, and potential investors came in an endless stream, with representatives from numerous professional investment institutions staying at the booth. They engaged in enthusiastic discussions with the company's team on core topics such as technical principles, clinical progress, business models, and future plans, showing strong interest.

Notably, in addition to investors, several ecosystem partners, including Huawei, also visited the booth to discuss technology integration, platform co-construction, and potential future collaborations in the AI field. This exhibition has also become an important window for Genlight Neurotech to expand its global presence, attracting medical institutions and channel partners from various countries such as Thailand, Brazil, Saudi Arabia, and India to engage in discussions with the hope of establishing partnerships.

On display this time is Epilcure, a closed-loop neuromodulation system independently developed by Genlight Neurotech. This system deeply integrates advanced brain-computer interface technology, real-time analysis algorithms for neuroelectrophysiological signals, and safe neural stimulation techniques, representing the cutting-edge direction in the field of refractory epilepsy treatment.

• "Perception" and "Decoding":The system captures characteristic brain electrical activity associated with epileptic seizures in real time through a high-precision implantable neural signal acquisition device.

• Intelligent "Decision-Making":Relying on a powerful algorithm platform, the system automatically identifies the pre-seizure or onset of epilepsy.

• Personalized "Intervention":Once abnormal brain electrical activity is detected, the system immediately triggers targeted, parameter-adjustable neuroelectrical stimulation to effectively suppress epileptic seizures.

• Data-Driven "Optimization":The system continuously records treatment data, constantly optimizing individualized detection and stimulation strategies for each patient.

This system aims to break through the limitations of traditional treatments, providing a smarter, more precise, and more effective treatment option for patients with drug-resistant epilepsy, improving their quality of life.

WAIC 2025 is still in full swing. Genlight Neurotech sincerely invites all friends who are interested in the latest developments in neuroscience, artificial intelligence, and digital therapeutics.On July 28 (Monday) and July 29 (Tuesday), head to the Shanghai World Expo Exhibition Center.Hall H2, Booth E920,We look forward to your visit.